A Study of FT-7051 in Men With MCRPC

NCT04575766 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: FT-7051

Sponsor

Novo Nordisk A/S